Abstract
New data suggest that zileuton [Abbott; preregistration] is an effective treatment for asthma in aspirin-sensitive patients. The results of studies involving patients with this difficult-to-treat condition were presented at an IBC USA conference on Asthma [Philadelphia, US; October 1995]. Delegates were also informed of the best options for managing patients with corticosteroid-dependent asthma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
